Saturday, April 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home DAX

Rheinmetall’s Record Order Book Can’t Mask a 52-Week Low as Q1 Results Approach

SiterGedge by SiterGedge
April 25, 2026
in DAX, Defense & Aerospace, Industrial
0
Rheinmetall Stock
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

The numbers coming out of Rheinmetall are the stuff of investor dreams — a €64 billion order backlog, a €2.4 billion drone contract, and revenue targets approaching €14.5 billion. Yet the Düsseldorf-based defence group finds itself in a peculiar bind: the more business it books, the lower its shares sink.

On Friday, the stock touched €1,321.20, a fresh 52-week trough that leaves it more than a third below the near-€2,000 peak hit last September. Since the start of 2026, the equity has shed roughly 17.5% of its value. The disconnect between operational momentum and market sentiment has rarely been starker.

A €2.4 Billion Drone Deal That Didn’t Move the Needle

The latest piece of good news arrived on 22 April, when the Bundeswehr’s procurement office signed a framework agreement for the FV-014 loitering munition, a so-called “kamikaze drone” produced by Rheinmetall. The ceiling value of the contract stands at around €2.4 billion, with an initial call-off of approximately 2,500 units worth €300 million gross. The Bundestag’s budget committee had given its blessing on 15 April.

The FV-014, internally designated “Raider,” is an electrically powered drone in the 20-kilogram class. It carries a 4-kilogram warhead, has a range of up to 100 kilometres, and can loiter for 70 minutes. The system is designed to operate in GPS-denied environments and supports swarm operations. Rheinmetall manufactures the drone entirely within the EU, with qualification expected by September 2026 and first deliveries pencilled in for the first half of 2027.

This marks the third loitering-munition contract awarded by the German military this year. In February, the budget committee approved framework deals with Helsing and STARK, each with initial call-offs around €270 million. The FV-014 systems are slated to equip, among others, the Panzerbrigade 45 stationed in Lithuania from 2027 onwards.

The Cashflow Conundrum

While headline orders look impressive, the financial mechanics behind them are weighing on the stock. Rheinmetall currently holds critical components worth roughly €8 billion in inventory — a strategic buffer that guarantees production continuity but ties up enormous amounts of working capital. The result is a drag on cash flow that has made investors cautious.

Chief executive Armin Papperger used his appearance at the Hannover Messe to showcase the group’s production ramp-up. Artillery munition output, he noted, has increased more than tenfold since the start of the Ukraine war, and unit costs are falling as volumes rise. Yet the market appears to be looking past the operational cheerleading and focusing on the balance sheet strain.

Should investors sell immediately? Or is it worth buying Rheinmetall?

Technicals Deteriorate

Chart watchers have little to cheer about. The stock is now trading roughly 20% below its 200-day moving average, a bearish signal that often prompts further selling. The slide has been relentless: from the September 2025 high, the shares have surrendered more than a third of their value, and the year-to-date decline stands at 17.5%.

The 52-week low of €1,321.20 undershoots even the most cautious analyst estimates. Jefferies, which recently lifted its price target to €2,220 with a “Buy” rating, argues that land-defence stocks look particularly attractive after the recent pullback. Bernstein Research maintains an “Outperform” call with a €2,050 target, while Berenberg sees value at €2,100. The consensus among sell-side analysts remains firmly bullish — but the market is voting with its feet.

Joint Venture for Cruise Missiles

Alongside the drone deal, Rheinmetall is pushing into new weapons categories. The company plans to form a joint venture with Destinus to produce cruise missiles and ballistic rocket artillery. The new entity will be based in Unterlüß, Lower Saxony, with Rheinmetall taking a 51% stake. Production is expected to begin in the second half of 2026, pending regulatory approval.

The move underscores the group’s ambition to capture a broader slice of Europe’s rearmament spending, but it also adds another layer of capital commitment at a time when investors are already fretting about cash conversion.

The Q1 Reckoning

All eyes now turn to 7 May, when Rheinmetall releases its first-quarter results for 2026. Five days later, the annual general meeting will take place. The company has guided for revenue growth of 40% to 45% this year, targeting €14.0 billion to €14.5 billion. Over 90% of that sum is already covered by existing orders, providing unusually high visibility.

The question is whether management can convince the market that the record backlog is translating into near-term earnings and, crucially, cash. The margin outlook disappointed in the previous update, and investors want hard numbers — not just order-book bragging rights. Until then, the gap between Rheinmetall’s operational reality and its stock price seems set to persist.

Ad

Rheinmetall Stock: Buy or Sell?! New Rheinmetall Analysis from April 25 delivers the answer:

The latest Rheinmetall figures speak for themselves: Urgent action needed for Rheinmetall investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 25.

Rheinmetall: Buy or sell? Read more here...

Tags: Rheinmetall
SiterGedge

SiterGedge

Related Posts

DAX Stock
DAX

German Blue-Chips Tread Water as Earnings Tsunami and ECB Verdict Loom

April 25, 2026
Thyssenkrupp Stock
Earnings

Thyssenkrupp’s Spring of Reckoning: A €37 Billion Canadian Bet Meets a Bleeding Steel Core

April 25, 2026
Deutsche Bank Stock
Banking & Insurance

Deutsche Bank’s April 29 Double Feature: Earnings and a Fed Decision Put the Stock to the Test

April 25, 2026
Next Post
Antimony Resources Stock

Antimony Resources Puts Bald Hill on the Cusp of a Formal Resource Count

TeamViewer Stock

TeamViewer’s Recovery Hangs on a Knife-Edge Ahead of Q1 Results

ImmunityBio Stock

ImmunityBio’s Record Revenue Overshadowed by FDA Fallout and Cash Burn

Recommended

InMed Pharmaceuticals Stock

InMed Pharmaceuticals: The Critical Search for Clinical Validation

1 month ago
Quantum Computing Inc Stock

Quantum Computing Stock Surges Following Major Capital Infusion

7 months ago
Finance_ Chart Down

Analyst at JP Morgan Increases Price Target for Intercontinental Exchange NYSEICE

2 years ago
Atmos Energy Stock

Looking Beyond the Dividend: Atmos Energy’s Strategic Foundation

8 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Newmont Mining Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

BioNTech’s Insider Sale Doesn’t Deter Wall Street as Oncology Pipeline Takes Center Stage

Alphabet’s $40 Billion Anthropic Wager Puts Cloud Earnings Under the Microscope

German Blue-Chips Tread Water as Earnings Tsunami and ECB Verdict Loom

Gold’s Correction Deepens as Oil Shock and Fed Uncertainty Reshape the Outlook

Bloom Energy’s AI-Powered Rally Faces a Reality Check Next Week

Apple’s China Comeback and CEO Succession Set the Stage for a Pivotal Earnings Report

Trending

Micron Stock
AI & Quantum Computing

Micron’s Political Gambit and Production Crunch: Inside the 424-Euro Rally

by Jackson Burston
April 25, 2026
0

The memory-chip maker Micron Technology has become a study in contrasts. Its shares hit a fresh 52-week...

ServiceNow Stock

ServiceNow’s $2 Billion Buyback Couldn’t Stop the Bleeding — But Bargain Hunters Are Circling

April 25, 2026
Vonovia Stock

Vonovia’s Triple Test: Rate Decision, Earnings, and AGM Converge in Tense Spring

April 25, 2026
BioNTech Stock

BioNTech’s Insider Sale Doesn’t Deter Wall Street as Oncology Pipeline Takes Center Stage

April 25, 2026
Alphabet Stock

Alphabet’s $40 Billion Anthropic Wager Puts Cloud Earnings Under the Microscope

April 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Micron’s Political Gambit and Production Crunch: Inside the 424-Euro Rally
  • ServiceNow’s $2 Billion Buyback Couldn’t Stop the Bleeding — But Bargain Hunters Are Circling
  • Vonovia’s Triple Test: Rate Decision, Earnings, and AGM Converge in Tense Spring

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com